BNC Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

BNC Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,045	Closed	-$835K	–	102
2023 Q1	$835K	Buy	12,045 +707	+6%	+$49.9K	0.47%	58
2022 Q4	$816K	Buy	+11,338	New	+$855K	0.48%	58
2020 Q4	–	Sell	-120	Closed	-$7K	–	142
2020 Q3	$7K	Buy	+120	New	+$7.22K	﹤0.01%	332

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BNC Wealth Management's BMY Position: Q2 2023 in Review

BNC Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 12,045 shares — an estimated $835K sold.

BNC Wealth Management first reported a position in BMY in Q3 2020 and held it in 3 quarters. The position peaked at $835K in Q1 2023. 2,483 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

BNC Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
BNC Wealth Management sold 12,045 Bristol-Myers Squibb shares in Q2 2023, an estimated $835K.
BNC Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 3 quarters.
BNC Wealth Management's Bristol-Myers Squibb position peaked at $835K in Q1 2023.
2,483 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on BNC Wealth Management's 13F filing for Q2 2023, filed 28 Jul 2023.